Brugada syndrome: genes and variants
Explore variant evidence for Brugada syndrome across 7 analyzed proteins (SCN5A, HCN4, SCN1B, CACNA1C, ANK2 and 2 more). Linked ClinVar records include 41 pathogenic or likely pathogenic variants, 1,795 variants of uncertain significance and 281 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Brugada syndrome
SCN5A: Sodium channel protein type 5 subunit alpha
Its rapid inward sodium current drives the upstroke of the cardiac action potential and enables fast electrical conduction through atrial, ventricular, and conduction-system tissue. Pathogenic variants can cause long-QT syndrome type 3, Brugada syndrome, conduction disease, and overlapping arrhythmia phenotypes.
24 ClinVar pathogenic / likely pathogenic and 77 uncertain variants in SCN5A have source records linked to Brugada syndrome. Association strength is not clinical gene validity.
HCN4: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
Its hyperpolarization-activated current contributes substantially to spontaneous diastolic depolarization in sinoatrial-node pacemaker cells. Pathogenic variants can cause sinus bradycardia, conduction abnormalities, and in some families left-ventricular noncompaction.
9 ClinVar pathogenic / likely pathogenic and 815 uncertain variants in HCN4 have source records linked to Brugada syndrome. Association strength is not clinical gene validity.
SCN1B: Sodium channel regulatory subunit beta-1
The beta-1 subunit of voltage-gated sodium channels, which regulates channel activity and cell adhesion. Pathogenic variants cause several forms of epilepsy, while associations with cardiac arrhythmias have also been reported.
4 ClinVar pathogenic / likely pathogenic and 143 uncertain variants in SCN1B have source records linked to Brugada syndrome. Association strength is not clinical gene validity.
CACNA1C: Voltage-dependent L-type calcium channel subunit alpha-1C
Its opening provides a major source of depolarization-triggered calcium entry in cardiomyocytes, smooth muscle, and neurons, coupling electrical activity to contraction and signaling. Pathogenic variants can cause Timothy syndrome, Brugada or long-QT phenotypes, and several neurodevelopmental disorders.
3 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in CACNA1C have source records linked to Brugada syndrome. Association strength is not clinical gene validity.
ANK2: Ankyrin-2
It organizes membrane proteins and ion-handling complexes by linking them to the cytoskeleton, with especially important roles in cardiomyocytes and neurons. Pathogenic variants can disrupt cardiac electrical organization and cause ankyrin-B syndrome, including sinus-node dysfunction, arrhythmias, and variable QT abnormalities.
1 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in ANK2 have source records linked to Brugada syndrome. Association strength is not clinical gene validity.
CACNB2: Voltage-dependent L-type calcium channel subunit beta-2
It regulates gating and membrane delivery of high-voltage-activated calcium channels, including cardiac Cav1.2. Rare pathogenic variants have been associated with cardiac arrhythmia and neurodevelopmental phenotypes, although variant-specific evidence is important when interpreting causality.
0 ClinVar pathogenic / likely pathogenic and 289 uncertain variants in CACNB2 have source records linked to Brugada syndrome. Association strength is not clinical gene validity.
SCN10A: Sodium channel protein type 10 subunit alpha
The protein forms Nav1.8, a tetrodotoxin-resistant voltage-gated sodium channel found in excitable membranes. It helps generate sensory-neuron electrical signals and is especially important in mechanisms of neuropathic pain and inherited episodic pain.
0 ClinVar pathogenic / likely pathogenic and 734 uncertain variants in SCN10A have source records linked to Brugada syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): DSP, TRPM4, ANKRD1, COL5A1, GATA4, KCNH2, KCNJ2, MYBPC3 and 1 more.
Where Brugada syndrome variants cluster
- HCN4 Segment H5 (positions 465–486): 6 of 9 ClinVar pathogenic / likely pathogenic variants, 36.5× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Brugada syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| HCN4 G480V | 480 | Segment H5 | Pathogenic / likely pathogenic (★★) |
| HCN4 G480S | 480 | Segment H5 | Pathogenic / likely pathogenic (★★) |
| HCN4 Y481H | 481 | Segment H5 | Pathogenic / likely pathogenic (★★) |
| SCN5A R121Q | 121 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1C G406R | 406 | I | Pathogenic / likely pathogenic (★★) |
| HCN4 G482R | 482 | Segment H5 | Pathogenic / likely pathogenic (★★) |
| HCN4 R375C | 375 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SCN5A R121W | 121 | I | Pathogenic / likely pathogenic (★★) |
| SCN5A R222Q | 222 | I | Pathogenic / likely pathogenic (★★) |
| SCN5A R367H | 367 | I | Pathogenic / likely pathogenic (★★) |
| SCN5A A735V | 735 | II | Pathogenic / likely pathogenic (★★) |
| SCN5A G752R | 752 | II | Pathogenic / likely pathogenic (★★) |
| SCN5A R878H | 878 | II | Pathogenic / likely pathogenic (★★) |
| SCN5A R893H | 893 | II | Pathogenic / likely pathogenic (★★) |
| SCN5A S1710L | 1710 | IV | Pathogenic / likely pathogenic (★★) |
| SCN5A G1740R | 1740 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1C M611T | 611 | II | Pathogenic / likely pathogenic (★★) |
| HCN4 Y354C | 354 | Segment S3 | Pathogenic / likely pathogenic (★★) |
| HCN4 A485V | 485 | Segment H5 | Pathogenic / likely pathogenic (★★) |
| SCN1B C121W | 121 | Ig-like C2-type | Pathogenic / likely pathogenic (★★) |
| SCN1B V158M | 158 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SCN5A E1784K | 1784 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1B R85H | 85 | Ig-like C2-type | Pathogenic / likely pathogenic (★★) |
| SCN5A G1319V | 1319 | III | Pathogenic / likely pathogenic (★★) |
| SCN5A G1743E | 1743 | IV | Pathogenic / likely pathogenic (★★) |
| HCN4 Y481C | 481 | Segment H5 | Pathogenic / likely pathogenic (★) |
| HCN4 D491H | 491 | Extracellular | Pathogenic / likely pathogenic (★) |
| SCN5A G400W | 400 | I | Pathogenic / likely pathogenic (★) |
| SCN5A V1323G | 1323 | III | Pathogenic / likely pathogenic (★) |
| SCN5A V1324G | 1324 | III | Pathogenic / likely pathogenic (★) |
| SCN5A F1473I | 1473 | III | Pathogenic / likely pathogenic (★) |
| SCN5A E1548K | 1548 | IV | Pathogenic / likely pathogenic (★) |
| ANK2 S2250L | 2250 | Pathogenic / likely pathogenic (★) | |
| SCN1B M1I | 1 | Pathogenic / likely pathogenic (★) | |
| SCN5A T1620M | 1620 | IV | Pathogenic / likely pathogenic |
| CACNA1C A39V | 39 | Cytoplasmic | Pathogenic / likely pathogenic |
| SCN5A V232I | 232 | I | Pathogenic / likely pathogenic |
| SCN5A R1232W | 1232 | III | Pathogenic / likely pathogenic |
| SCN5A L1308F | 1308 | III | Pathogenic / likely pathogenic |
| SCN5A F1571L | 1571 | IV | Pathogenic / likely pathogenic |
| SCN5A Y1795H | 1795 | IV | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Brugada syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| HCN4 Y481L | 481 | Segment H5 | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; Y481H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
Which prediction tools work for Brugada syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 94 out of 100
- AlphaMissense: 94 out of 100
- MutPred: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 88 out of 100
- PolyPhen-2: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 87 out of 100
- SIFT: 84 out of 100
- CADD: 78 out of 100
- SpliceAI: 55 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 50 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Cardiac arrhythmia also has ClinVar records linked to SCN5A variants; they fall mostly in different places as the Brugada syndrome variants (17 pathogenic / likely pathogenic).
- Long QT syndrome also has ClinVar records linked to SCN5A variants; they fall mostly in different places as the Brugada syndrome variants (16 pathogenic / likely pathogenic).
- Progressive familial heart block also has ClinVar records linked to SCN5A variants; they fall mostly in different places as the Brugada syndrome variants (4 pathogenic / likely pathogenic).
- Familial atrial fibrillation also has ClinVar records linked to SCN5A variants; they fall mostly in different places as the Brugada syndrome variants (3 pathogenic / likely pathogenic).
- Sick sinus syndrome also has ClinVar records linked to HCN4 variants; they fall mostly in different places as the Brugada syndrome variants (4 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to SCN1B variants; they fall partly in the same places as the Brugada syndrome variants (3 pathogenic / likely pathogenic).
- Long QT syndrome also has ClinVar records linked to CACNA1C variants; they fall mostly in different places as the Brugada syndrome variants (12 pathogenic / likely pathogenic).
- Timothy syndrome also has ClinVar records linked to CACNA1C variants; they fall mostly in different places as the Brugada syndrome variants (4 pathogenic / likely pathogenic).
- Long QT syndrome also has ClinVar records linked to ANK2 variants; they fall mostly in different places as the Brugada syndrome variants (3 pathogenic / likely pathogenic).
Diseases related to Brugada syndrome
- Cardiac arrhythmia, also linked to ANK2, CACNA1C, HCN4, SCN10A and 1 more
- Epilepsy, also linked to CACNA1C, CACNB2, SCN10A and SCN5A
- Long QT syndrome, also linked to ANK2, CACNA1C and SCN5A
- Familial atrial fibrillation, also linked to SCN1B and SCN5A
- Progressive familial heart block, also linked to SCN1B and SCN5A
- Sick sinus syndrome, also linked to HCN4 and SCN5A
- Focal epilepsy, also linked to SCN10A and SCN5A
- Migraine, also linked to SCN10A and SCN5A
- Developmental and epileptic encephalopathy, also linked to SCN1B
- Hypertrophic cardiomyopathy, also linked to ANK2
- Amyotrophic lateral sclerosis, also linked to SCN10A
- Dilated cardiomyopathy, also linked to SCN5A
Frequently asked questions
Which genes have records linked to Brugada syndrome?
This view contains 7 analyzed proteins: SCN5A, HCN4, SCN1B, CACNA1C, ANK2 and 2 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 41 pathogenic or likely pathogenic variants, 1,795 variants of uncertain significance and 281 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 2,297 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center